Subcutaneous injection of IHP-102 prevents lung vaso-occlusion in sickle cell disease mice

Affiliations

• ¹ Thrombosis and Hemostasis Program, VERSITI Blood Research Institute, Milwaukee, WI, USA; Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA.
• ² Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA.
• ³ Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA.
• ⁴ Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.
• ⁵ IHP Therapeutics, San Carlos, CA.
• ⁶ Thrombosis and Hemostasis Program, VERSITI Blood Research Institute, Milwaukee, WI, USA; Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Sickle Cell Center of Excellence, University of Pittsburgh, Pittsburgh, PA. [email protected].